Sadaf Davudian

2.2k total citations · 1 hit paper
8 papers, 1.7k citations indexed

About

Sadaf Davudian is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Sadaf Davudian has authored 8 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Pathology and Forensic Medicine and 2 papers in Oncology. Recurrent topics in Sadaf Davudian's work include PARP inhibition in cancer therapy (2 papers), RNA Research and Splicing (2 papers) and Cancer therapeutics and mechanisms (1 paper). Sadaf Davudian is often cited by papers focused on PARP inhibition in cancer therapy (2 papers), RNA Research and Splicing (2 papers) and Cancer therapeutics and mechanisms (1 paper). Sadaf Davudian collaborates with scholars based in Iran, Australia and Italy. Sadaf Davudian's co-authors include Behzad Baradaran, Behzad Mansoori, Ali Mohammadi, Solmaz Shirjang, Neda Shajari, Dariush Shanehbandi, Tohid Kazemi, Vahid Khaze, Pascal H. G. Duijf and Milad Asadi and has published in prestigious journals such as Gene, Biomedicine & Pharmacotherapy and Artificial Cells Nanomedicine and Biotechnology.

In The Last Decade

Sadaf Davudian

8 papers receiving 1.6k citations

Hit Papers

The Different Mechanisms ... 2017 2026 2020 2023 2017 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sadaf Davudian Iran 6 1.0k 419 396 192 174 8 1.7k
Cristina P. R. Xavier Portugal 20 1.2k 1.2× 443 1.1× 509 1.3× 246 1.3× 137 0.8× 46 1.9k
Khalid O. Alfarouk Saudi Arabia 18 1.2k 1.2× 407 1.0× 683 1.7× 181 0.9× 132 0.8× 46 2.0k
Qiwei Jiang China 27 1.1k 1.1× 421 1.0× 389 1.0× 132 0.7× 155 0.9× 61 1.9k
Qingbin Cui China 22 1.0k 1.0× 679 1.6× 285 0.7× 229 1.2× 115 0.7× 49 1.8k
Tina S. Homayouni Canada 4 999 1.0× 430 1.0× 223 0.6× 310 1.6× 242 1.4× 4 1.9k
Narges Baluch Canada 11 1.1k 1.0× 475 1.1× 236 0.6× 333 1.7× 258 1.5× 17 2.2k
Mysore S. Veena United States 19 944 0.9× 308 0.7× 327 0.8× 88 0.5× 168 1.0× 28 1.9k
Solmaz Shirjang Iran 16 1.5k 1.4× 498 1.2× 823 2.1× 227 1.2× 223 1.3× 18 2.4k
Karol Bukowski Poland 8 678 0.7× 370 0.9× 227 0.6× 210 1.1× 194 1.1× 16 1.3k
Béla Ózsvári United Kingdom 26 1.2k 1.2× 542 1.3× 635 1.6× 271 1.4× 142 0.8× 40 2.3k

Countries citing papers authored by Sadaf Davudian

Since Specialization
Citations

This map shows the geographic impact of Sadaf Davudian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sadaf Davudian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sadaf Davudian more than expected).

Fields of papers citing papers by Sadaf Davudian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sadaf Davudian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sadaf Davudian. The network helps show where Sadaf Davudian may publish in the future.

Co-authorship network of co-authors of Sadaf Davudian

This figure shows the co-authorship network connecting the top 25 collaborators of Sadaf Davudian. A scholar is included among the top collaborators of Sadaf Davudian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sadaf Davudian. Sadaf Davudian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Changizi‐Ashtiyani, Saeed, et al.. (2018). Protective effects of omega-3, atorvastatin, vitamin E and vitamin C against doxorubicin-induced cardiotoxicity in rats: a comparison study. 22(1). 63–72. 3 indexed citations
2.
Mansoori, Behzad, Ali Mohammadi, Sadaf Davudian, Solmaz Shirjang, & Behzad Baradaran. (2017). The Different Mechanisms of Cancer Drug Resistance: A Brief Review. Advanced Pharmaceutical Bulletin. 7(3). 339–348. 1384 indexed citations breakdown →
3.
Shajari, Neda, Sadaf Davudian, Tohid Kazemi, et al.. (2017). Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expression. Artificial Cells Nanomedicine and Biotechnology. 46(7). 1495–1504. 51 indexed citations
4.
Davudian, Sadaf, Behzad Mansoori, Neda Shajari, Ali Mohammadi, & Behzad Baradaran. (2016). BACH1, the master regulator gene: A novel candidate target for cancer therapy. Gene. 588(1). 30–37. 93 indexed citations
5.
Mohammadi, Ali, Behzad Mansoori, Mahyar Aghapour, et al.. (2016). The Herbal Medicine Utrica Dioica Inhibits Proliferation of Colorectal Cancer Cell Line by Inducing Apoptosis and Arrest at the G2/M Phase. Journal of Gastrointestinal Cancer. 47(2). 187–195. 27 indexed citations
6.
Davudian, Sadaf, Neda Shajari, Tohid Kazemi, et al.. (2016). BACH1 silencing by siRNA inhibits migration of HT-29 colon cancer cells through reduction of metastasis-related genes. Biomedicine & Pharmacotherapy. 84. 191–198. 50 indexed citations
7.
Shajari, Neda, Behzad Mansoori, Sadaf Davudian, Ali Mohammadi, & Behzad Baradaran. (2016). Overcoming the Challenges of siRNA Delivery: Nanoparticle Strategies. Current Drug Delivery. 14(1). 36–46. 48 indexed citations
8.
Mansoori, Behzad, et al.. (2016). Nano-liposome-based target toxicity machine: an alternative/complementary approach in atopic diseases. Artificial Cells Nanomedicine and Biotechnology. 45(7). 1292–1297. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026